Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-08

Clinical Trial Update: Study of Kuvan Treatment in Adults With GTPCH Deficiency [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Kuvan (sapropterin dihydrochloride) in adults with GTP cyclohydrolase I deficiency has completed, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: University of Utah | Conditions: GTP Cyclohydrolase Deficiency | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-08